Original title: A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery
Some microbes resist antibiotics, so medicines that once worked may fail. Plants make many natural chemicals, called secondary metabolitesChemicals made by plants that are not part of their basic growth processes., that could affect microbes. This review examines whether plant compounds might serve as new antibiotics or help existing antibiotics work again. It also considers how these compounds could be developed into treatments compatible with the body.
Imagine a lock that has stopped opening with the key you usually use. You could search for a new key, or look for something that helps the old key work again. In this paper, the keys are antibiotics, the stubborn lock stands for resistant microbes, and plant compounds are explored as possible new keys or helpers for the old one.
Drug-resistant microbes can make infections harder to treat, while the misuse of antibiotics has helped resistance emerge. This review looks at whether plant compounds could supply new treatments or help restore the effect of existing antibiotics.
The abstract describes a review focused on the potential of plant compounds; it does not report clinical evidence that they treat infections in people, establish which plants or compounds work best, or show that they can safely restore antibiotic effectiveness.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
A Comprehensive Review on Medicinal Plants as Antimicrobial Therapeutics: Potential Avenues of Biocompatible Drug Discovery — Uttpal Anand, Nadia Judith Jacobo-Herrera, Ammar B. Altemimi et al. — Metabolites — doi:10.3390/metabo9110258
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.